Malin Corporation | MLC - Cash And Equivalent

Stock Price
7.95
Daily Change
0 0%
Monthly
3.25%
Yearly
-6.47%
Q2 Forecast
7.71

Malin Corporation reported EUR62.1M in Cash and Equivalent for its fiscal semester ending in December of 2024.





Cash And Equivalent Change Date
Akebia Therapeutics USD 184.84M 18.4M Dec/2025
Alaunos Therapeutics USD 1.94M 941K Sep/2025
ALKERMES USD 388.57M 227.88M Dec/2025
Avita Medical AUD 10.24M 1.98M Dec/2025
Dianthus Therapeutics USD 51.09M 4.9M Dec/2025
Eurofins Scientific SE EUR 791.2M 37.9M Dec/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Lonza CHF 719M 188M Dec/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Moderna USD 2.6B 1.46B Dec/2025
Organon & Co USD 672M 73M Sep/2025
Revvity USD 919.86M 11.53M Dec/2025
Tectonic Therapeutic USD 253.8M 14.64M Dec/2025
Viatris USD 1.32B 347.1M Dec/2025
Xeris Pharmaceuticals USD 111.04M 19.44M Dec/2025